Skip to main content

Feature Article - Quietly weathering the storm

Carolyn Buller of Squire Patton Boggs takes a look back at a year like no other in chemicals

Squire Patton Boggs (SPB), a global law firm, has about one third of the top 60 chemical companies as clients and is constantly speaking with the industry about ongoing trends. The COVID-19 pandemic has made forecasting an even more treacherous business than ever and it is always hard to generalise over so broad a concept as speciality chemicals. ‘Specialities’ are a never-ending game – everything is or was a speciality until, one day, it no longer is.

Feature article - A CDMO’s insight into the M&A landscape

Mark Quick, EVP of  corporate development at Recipharm, discusses the M&A trend within the CDMO industry

M&A activity within the pharmaceutical industry remains at a high. According to Ernst & Young (EY), M&A strategies have increased by around 12% year-on-year since 2012.1 CDMOs are some of the major players in these high-value deals, seeing it as a valuable strategy that enables to capitalise on another company’s strengths and thus better position their organisations to meet market demands and realise a more competitive edge.

Ascensus to buy Callery

Ascensus Specialties, which claims to be the largest global producer of dry and liquid sodium borohydride (SBH), has agreed to acquire Callery from private equity firm, Edgewater Capital.
Subscribe to M&A